BioCardia Closes Merger With Tiger X Medical, Inc.

Tuesday, October 25, 2016

BioCardia, Inc. today announced completion of its merger with Tiger X Medical, Inc. effective today. In connection with the merger, Tiger X Medical will change its name to BioCardia, Inc. The combined company will commence trading under the symbol “BCDA” as of the open of market October 26, 2016 on OTC PINK.

Immediately prior to the merger, BioCardia converted all outstanding convertible promissory notes into shares of common stock, and the combined company has approximately $25 million in cash available, before the payment of fees and expenses.

“We are very pleased to complete this merger, which marks a significant milestone for BioCardia. We are transitioning from a private company to a publicly-traded company through this merger, and significantly increasing our financial resources,” said Dr. Peter Altman, President and CEO of BioCardia. “These funds are expected to support operations and enable us to advance our pivotal Phase 3 CardiAMP cell therapy program for the treatment of heart failure developed after a heart attack.”

 

Source : finance.yahoo.com